TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/12/22 18:50 | 1/11/22 | NEO | Neogenomics Inc | NV | Health | Biolab | Testing Laboratories | McKenzie Kathryn B | FL | O | Chief Su | M.d | 19 | 9.07 | 0 | 2 | 4 | 49 | D | ||||||||||||||
12/23/21 17:25 | 12/21/21 | NEO | Neogenomics Inc | NV | Health | Biolab | Testing Laboratories | McKenzie Kathryn B | FL | O | CFO | S.d | -65 | 35.00 | 0 | -2 | -10 | 17 | D | ||||||||||||||
12/23/21 17:25 | 12/22/21 | NEO | Neogenomics Inc | NV | Health | Biolab | Testing Laboratories | McKenzie Kathryn B | FL | O | CFO | M.d | 45 | 9.07 | 0 | 5 | 43 | 17 | D | ||||||||||||||
12/12/19 19:28 | 12/10/19 | NEO | Neogenomics Inc | NV | Health | Biolab | Testing Laboratories | McKenzie Kathryn B | FL | O | Chief Ac | M.d | 64 | 8.03 | 0 | 8 | 2 | D | |||||||||||||||
12/12/19 19:28 | 12/10/19 | NEO | Neogenomics Inc | NV | Health | Biolab | Testing Laboratories | McKenzie Kathryn B | FL | O | Chief Ac | S.d | -211 | 26.37 | 0 | -8 | -78 | 2 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |